B. Metzler seel. Sohn & Co’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.32M Buy
40,521
+1,278
+3% +$155K 0.04% 269
2026
Q1
$6.42M Buy
39,243
+34,510
+729% +$5.31M 0.06% 180
2025
Q4
$824K Sell
4,733
-348
-7% -$63.5K 0.01% 573
2025
Q3
$732K Sell
5,081
-5,429
-52% -$665K 0.01% 599
2025
Q2
$1.06M Hold
10,510
– – 0.01% 530
2025
Q1
$802K Hold
10,510
– – 0.01% 568
2024
Q4
$726K Hold
10,510
– – 0.01% 595
2024
Q3
$767K Buy
+10,510
New +$776K 0.01% 592
2024
Q2
– Sell
-18,672
Closed -$507K – 771
2024
Q1
$507K Hold
18,672
– – 0.01% 618
2023
Q4
$579K Buy
18,672
+2,051
+12% +$53.2K 0.01% 593
2023
Q3
$420K Sell
16,621
-13,969
-46% -$319K 0.01% 603
2023
Q2
$645K Buy
30,590
+16,423
+116% +$312K 0.01% 551
2023
Q1
$242K Buy
14,167
+955
+7% +$18.6K ﹤0.01% 665
2022
Q4
$264K Hold
13,212
– – ﹤0.01% 650
2022
Q3
$285K Buy
13,212
+1,076
+9% +$25.8K 0.01% 643
2022
Q2
$239K Hold
12,136
– – ﹤0.01% 679
2022
Q1
$285K Buy
+12,136
New +$282K ﹤0.01% 698

Other funds holding INSM

B. Metzler seel. Sohn & Co's INSM Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Insmed (INSM) stake by 3.3% in Q2 2026, buying an estimated $155K and bringing the position to 40,521 shares worth $4.32M. The position accounts for 0.04% of the portfolio, ranked #269.

B. Metzler seel. Sohn & Co first reported a position in INSM in Q1 2022 and has held it in 17 quarters since. The position peaked at $6.42M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 40,521 shares of Insmed worth $4.32M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 1,278 Insmed shares in Q2 2026, an estimated $155K.
  • Insmed made up 0.04% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #269 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Insmed in Q1 2022 and has held it in 17 quarters since.
  • B. Metzler seel. Sohn & Co's Insmed position peaked at $6.42M in Q1 2026.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.